Casino Knight
OPColdJoke
:
If you think you are gonna earn $8 per share, throw all your life savings here then. Pfizer being force to buy at $100 per share to gain access to their data and drugs doesn't equate to the value of the share being worth $100. Unless Pfizer doubles their profit and revenue by helping the company grow, which is possible but takes time.
ColdJoke
Casino Knight
OP
:
don‘t worry, pfizer has the money. ARNA is clinical stage so large institute won’t want to wait for more years. I just load large position but not all for sure. Risk apparently is: if deal is withdrawn (not happening in a few week so I can do research) then back to normal price.
Casino Knight
OPColdJoke
:
All the best to your predictions, I myself have loaded on Puts that expires this week and end of year as my take on this situation is different from yours.
Casino Knight
OPDusk till Dawn
:
I can't tell you what to buy exactly as I still have a chance to be wrong but I can share with you what I bought and the reason behind it. I bought 20 Puts option when it is at +85% predicting a decent fall by the end of this week as although Pfizer bought it at $100 per share, Pfizer's main goal is to acquire the company's drug patents and data. They have no intention of growing the company. Maybe in the future but it's impossible to do it within a period of few weeks thus institutions will not hold it for long. If an institution dumps it you will be looking at a chain reaction causing it to freefall. Hope it helps.
Dusk till Dawn
Casino Knight
OP
:
Thanks alot for ur reply. Good information. No worries, as I will not hold u accountable. I have to do my own DD. Hope u got ur puts right. Cheers
ColdJoke
Dusk till Dawn
:
appreciate Casino‘s insightful view. I just read sec filings, this one is different from other acquisition I experienced. I would reduce position with good price and take profit hopefully. Cost of quitting agreement is 235M. Expect to close in first half of 2022. ARNA will have first ever phase 3 readout in Q1. Pfizer definitely has inside data, but phase 3 double blind who knows, If result is bad… Pfizer will walk away. It’s not one with FDA approval (have proved themselves) nor one with just phase 1/2 that buyer don’t have time to disapprove.
ColdJoke : really? Read the news! Buy here and receive 8 dollars in a few months
Casino Knight OP ColdJoke : If you think you are gonna earn $8 per share, throw all your life savings here then. Pfizer being force to buy at $100 per share to gain access to their data and drugs doesn't equate to the value of the share being worth $100. Unless Pfizer doubles their profit and revenue by helping the company grow, which is possible but takes time.
ColdJoke Casino Knight OP : don‘t worry, pfizer has the money. ARNA is clinical stage so large institute won’t want to wait for more years. I just load large position but not all for sure. Risk apparently is: if deal is withdrawn (not happening in a few week so I can do research) then back to normal price.
Casino Knight OP ColdJoke : All the best to your predictions, I myself have loaded on Puts that expires this week and end of year as my take on this situation is different from yours.
Dusk till Dawn Casino Knight OP : Any tips for guidance?
I am still learning call/put.
Thanks
Casino Knight OP Dusk till Dawn : I can't tell you what to buy exactly as I still have a chance to be wrong but I can share with you what I bought and the reason behind it. I bought 20 Puts option when it is at +85% predicting a decent fall by the end of this week as although Pfizer bought it at $100 per share, Pfizer's main goal is to acquire the company's drug patents and data. They have no intention of growing the company. Maybe in the future but it's impossible to do it within a period of few weeks thus institutions will not hold it for long. If an institution dumps it you will be looking at a chain reaction causing it to freefall. Hope it helps.
Dusk till Dawn Casino Knight OP : Thanks alot for ur reply.
Good information.
No worries, as I will not hold u accountable.
I have to do my own DD.
Hope u got ur puts right.
Cheers
ColdJoke Dusk till Dawn : appreciate Casino‘s insightful view. I just read sec filings, this one is different from other acquisition I experienced. I would reduce position with good price and take profit hopefully. Cost of quitting agreement is 235M. Expect to close in first half of 2022. ARNA will have first ever phase 3 readout in Q1. Pfizer definitely has inside data, but phase 3 double blind who knows, If result is bad… Pfizer will walk away. It’s not one with FDA approval (have proved themselves) nor one with just phase 1/2 that buyer don’t have time to disapprove.